CellOrigin Biotech
CellOrigin Biotech and Qilu Pharmaceutical are co-developing allogeneic iPSC-derived chimeric antigen receptor macrophages (CAR-iMAC) to assist in the treatment of cancer.
CEO
Legal Name
CellOrigin Technology (Hangzhou) Co., Ltd.
Company Operating Status
Active
Country
Crunchbase URL
Email Address
info@cell-origin.com
0
Founder
Full Address
21st Floor, Building 4, 1500 Wenyi West Road, Yuhang District, Hangzhou
0
LinkedIn URL
Location
Phone Number
+17805815679
Pitchbook URL
Official Website
Find more companies like CellOrigin Biotech
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.